NO306448B1 - Suppositorium for rektal administrering - Google Patents

Suppositorium for rektal administrering

Info

Publication number
NO306448B1
NO306448B1 NO954783A NO954783A NO306448B1 NO 306448 B1 NO306448 B1 NO 306448B1 NO 954783 A NO954783 A NO 954783A NO 954783 A NO954783 A NO 954783A NO 306448 B1 NO306448 B1 NO 306448B1
Authority
NO
Norway
Prior art keywords
rectal administration
administration suppository
suppository
rectal
administration
Prior art date
Application number
NO954783A
Other languages
English (en)
Norwegian (no)
Other versions
NO954783D0 (no
NO954783L (no
Inventor
Isabelle Thielemans
Isabelle Richard
Original Assignee
Glaxo Wellcome Sa Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Wellcome Sa Lab filed Critical Glaxo Wellcome Sa Lab
Publication of NO954783D0 publication Critical patent/NO954783D0/no
Publication of NO954783L publication Critical patent/NO954783L/no
Publication of NO306448B1 publication Critical patent/NO306448B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
NO954783A 1993-05-25 1995-11-24 Suppositorium for rektal administrering NO306448B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB939310756A GB9310756D0 (en) 1993-05-25 1993-05-25 Compositions
PCT/EP1994/001652 WO1994027599A1 (fr) 1993-05-25 1994-05-24 Compositions a administration par voie rectale

Publications (3)

Publication Number Publication Date
NO954783D0 NO954783D0 (no) 1995-11-24
NO954783L NO954783L (no) 1995-11-24
NO306448B1 true NO306448B1 (no) 1999-11-08

Family

ID=10736089

Family Applications (1)

Application Number Title Priority Date Filing Date
NO954783A NO306448B1 (no) 1993-05-25 1995-11-24 Suppositorium for rektal administrering

Country Status (38)

Country Link
US (1) US5741806A (fr)
EP (1) EP0700290B1 (fr)
JP (1) JP2965703B2 (fr)
KR (1) KR100297212B1 (fr)
CN (1) CN1106194C (fr)
AP (1) AP544A (fr)
AT (1) ATE183643T1 (fr)
AU (1) AU680918B2 (fr)
BE (1) BE1007158A3 (fr)
BR (1) BR1100046A (fr)
CA (1) CA2162919C (fr)
CO (1) CO4230094A1 (fr)
CY (1) CY2411B1 (fr)
CZ (1) CZ291041B6 (fr)
DE (1) DE69420266T2 (fr)
DK (1) DK0700290T3 (fr)
EC (1) ECSP941088A (fr)
ES (1) ES2136198T3 (fr)
FR (1) FR2705569B1 (fr)
GB (2) GB9310756D0 (fr)
GR (1) GR3031669T3 (fr)
HR (2) HRP940315B1 (fr)
HU (1) HU227121B1 (fr)
IE (1) IE80632B1 (fr)
IL (1) IL109749A (fr)
IS (1) IS1868B (fr)
IT (1) IT1272990B (fr)
MY (1) MY111445A (fr)
NO (1) NO306448B1 (fr)
NZ (1) NZ267415A (fr)
PE (1) PE13395A1 (fr)
PL (1) PL175578B1 (fr)
RU (1) RU2132684C1 (fr)
SA (1) SA94150003B1 (fr)
SG (1) SG48119A1 (fr)
SI (1) SI0700290T1 (fr)
WO (1) WO1994027599A1 (fr)
ZA (1) ZA943593B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TR200103057T2 (tr) 1998-06-15 2002-06-21 Sepracor Inc. Apne, bulimi ve başka bozuklukların tedavi edilmesi için optik açıdan saf (+)-norsisapridin kullanımı
EP1468685A3 (fr) * 1998-06-15 2004-12-15 Sepracor Inc. Procedes permettant de traiter l'apnee, la boulimie et d'autres troubles au moyen du norcisapride (+) optiquement pur
EP1464333A3 (fr) * 1998-06-15 2004-12-15 Sepracor Inc. Procedes permettant de traiter l'apnee, la boulimie et d'autres troubles au moyen du norcisapride (-) optiquement pur
JP2003522103A (ja) * 1998-06-15 2003-07-22 セプラコア インコーポレーテッド 無呼吸、過食症およびその他の障害を治療するための光学的に純粋な（−）−ノルシスアプリドの使用
US6362202B1 (en) 1999-03-02 2002-03-26 Sepracor Inc. Methods and compositions using (−) norcisapride in combination with proton pump inhibitors or H2 receptor antagonists
US6353005B1 (en) 1999-03-02 2002-03-05 Sepracor, Inc. Method and compositions using (+) norcisapride in combination with proton pump inhibitors or H2 receptor antagonist
CN100553636C (zh) * 2000-08-04 2009-10-28 Dmi生物科学公司 二酮基哌嗪和包含它们的组合物的使用方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE460359B (sv) * 1984-01-25 1989-10-02 Glaxo Group Ltd 3-imidazolylmetyltetrahydrokarbazoloner, foerfarande foer framstaellning av dessa och en farmaceutisk komposition
US4695578A (en) * 1984-01-25 1987-09-22 Glaxo Group Limited 1,2,3,9-tetrahydro-3-imidazol-1-ylmethyl-4H-carbazol-4-ones, composition containing them, and method of using them to treat neuronal 5HT function disturbances
GB8516083D0 (en) * 1985-06-25 1985-07-31 Glaxo Group Ltd Heterocyclic compounds
GB8627909D0 (en) * 1986-11-21 1986-12-31 Glaxo Group Ltd Medicaments
GB8816187D0 (en) * 1988-07-07 1988-08-10 Glaxo Group Ltd Medicaments
GB8914804D0 (en) * 1989-06-28 1989-08-16 Glaxo Group Ltd Process
US5166145A (en) * 1990-09-10 1992-11-24 Alza Corporation Antiemetic therapy

Also Published As

Publication number Publication date
GB9409835D0 (en) 1994-07-06
ITRM940322A0 (it) 1994-05-24
SG48119A1 (en) 1998-04-17
AU6970994A (en) 1994-12-20
HU227121B1 (en) 2010-07-28
PL175578B1 (pl) 1999-01-29
AU680918B2 (en) 1997-08-14
HRP940315B1 (en) 2000-12-31
NO954783D0 (no) 1995-11-24
NZ267415A (en) 1997-10-24
KR100297212B1 (ko) 2001-10-24
EP0700290A1 (fr) 1996-03-13
US5741806A (en) 1998-04-21
HUT74867A (en) 1997-02-28
HU9503375D0 (en) 1996-01-29
PE13395A1 (es) 1995-05-25
SI0700290T1 (en) 1999-12-31
JPH08510457A (ja) 1996-11-05
CZ291041B6 (cs) 2002-12-11
DE69420266D1 (de) 1999-09-30
BE1007158A3 (fr) 1995-04-11
DK0700290T3 (da) 2000-03-13
CZ308595A3 (en) 1996-06-12
GB2279008A (en) 1994-12-21
JP2965703B2 (ja) 1999-10-18
CA2162919C (fr) 1999-07-20
ATE183643T1 (de) 1999-09-15
IS1868B (is) 2003-05-02
CN1106194C (zh) 2003-04-23
NO954783L (no) 1995-11-24
AP544A (en) 1996-10-11
CN1124454A (zh) 1996-06-12
HRP940315A2 (en) 1996-08-31
GR3031669T3 (en) 2000-02-29
CO4230094A1 (es) 1995-10-19
IE80632B1 (en) 1998-10-21
HRP970315A2 (en) 1999-04-30
CA2162919A1 (fr) 1994-12-08
GB9310756D0 (en) 1993-07-14
ZA943593B (en) 1995-02-13
MY111445A (en) 2000-05-31
ITRM940322A1 (it) 1995-11-24
AP9400643A0 (en) 1994-07-31
IE940420A1 (en) 1994-11-30
FR2705569A1 (fr) 1994-12-02
BR1100046A (pt) 1999-11-23
IL109749A0 (en) 1994-08-26
WO1994027599A1 (fr) 1994-12-08
GB2279008B (en) 1997-06-18
IL109749A (en) 1999-03-12
IS4168A (is) 1994-11-26
ECSP941088A (es) 1994-11-16
EP0700290B1 (fr) 1999-08-25
DE69420266T2 (de) 1999-12-09
SA94150003B1 (ar) 2005-04-11
IT1272990B (it) 1997-07-01
ES2136198T3 (es) 1999-11-16
RU2132684C1 (ru) 1999-07-10
PL311721A1 (en) 1996-03-04
CY2411B1 (en) 2004-11-12
FR2705569B1 (fr) 1995-11-10

Similar Documents

Publication Publication Date Title
DE59409564D1 (de) Kühlflüssigkeitsleitung
DE69425492D1 (de) Rektalsonde
DE59408767D1 (de) Kühlflüssigkeitsleitung
FI932741A0 (fi) Mjukvaevnadsfilteranordning till kefalostat
FI933978L (fi) Bioeroderbart antikonceptionssuppositiorium
ES1021151Y (es) Supositorio
NO306448B1 (no) Suppositorium for rektal administrering
FI933489A7 (fi) Salaojaputki
NO933444D0 (no) Linearrangement
DK121592D0 (da) Suppositorium
DK0617221T3 (da) Rørforbindelse
DE69422212D1 (de) Unterbrechungsanordnung
DK0627590T3 (da) Rørforbindelse
KR950016748U (ko) 관장기구
KR950016749U (ko) 관장기구
SE9302668D0 (sv) Enslinjen
FI943693A7 (fi) Jatkoliitos putkia varten
KR940016029U (ko) 암거의 하부판
FI924639L (fi) Farmaceutiska kompositioner innehaollande triazolderivat foer rektal administration
FI919U1 (fi) Skakel till dragackja
FI1025U1 (fi) Stampenhet till asfalteringsmaskin
FI914U1 (fi) Tillaeggsanordning till skottkaerra
FI944U1 (fi) Paobyggnadssidor till en skottkaerra
FI769U1 (fi) Tillaeggsanordning till sparkstoetting
FI910U1 (fi) Spetsdel till fiskeredskap

Legal Events

Date Code Title Description
MK1K Patent expired